share_log

板块异动 | 多地整治医美乱象引导行业健康发展 美容护理板块异动拉升

Changes in the sector | Remediating medical and aesthetic chaos in many places guides the healthy development of the industry, and changes in the beauty care sector rise

Zhitong Finance ·  Dec 15, 2022 09:52

The Zhitong Finance App learned that on December 15, due to news that rectifying medical and aesthetic chaos in many places is leading the healthy development of the industry, the A-share beauty care sector fluctuated and rose. As of press release, Qingdao Jinwang (002094.SZ) rose and stopped, while stocks such as Shanghai Home Chemical (600315.SH), Bethenny (300957.SZ), Lafang Home Chemical (603630.SH), and Reliability Co., Ltd. (301009.SZ) followed suit.

Recently, activities to rectify chaos in the medical beauty industry have been carried out in many places. Among them, the Market Supervision Bureau of Yichun City in Jiangxi Province carried out popularization campaigns on laws and regulations related to the medical and aesthetic industry. The Market Supervision Bureau of Zhaoqing City, Guangdong Province issued a cautionary note on medical beauty advertising activities. The Yunnan Provincial Market Supervision Bureau rectified the chaos in medical and beauty advertisements, etc.

Debon Securities believes that the current overall policy of the medical and aesthetic industry does not change the crackdown on illegal chaos; the purpose is to guide the healthy development of the industry. Supervision mainly targets criminal cases. In its nature, like investigating and punishing taxes, it targets illegal acts, rather than attacks on the medical and aesthetic industry and business models. Currently, in terms of regulatory policies, medicine and aesthetics are more meticulous about the details of supervision, raising the cost of breaking the law and making mistakes, which is beneficial to leading enterprises in the industry to increase their market share.

According to the Zheshang Securities Research Report, market expectations have moved from pessimism to optimism after the epidemic; with the verification of the second growth curve, the valuation system is expected to be interpreted on a more optimistic high growth track.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment